Posts by: Marisa Wexler, MS

Marisa Wexler, MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

March 6, 2020March 6, 2020

Lower Income Linked to Increased Risk of Lupus Nephritis, New Study Finds

News

Lower income is associated with a significantly higher risk of certain kidney diseases, including lupus nephritis, a new study found. The study, “Socioeconomic Position and Incidence of Glomerular Diseases,” was ... Read more

March 4, 2020March 4, 2020

Black Women with SLE Find Self-Management Program Improves Health

News

An educational program done in small, local, and peer-led groups, called the Chronic Disease Self‐Management Program, was seen as helpful by African-American women with systemic lupus erythematosus (SLE), improving their ... Read more

February 17, 2020February 17, 2020

SLE Associated With Hypertensive Disorders in Pregnancy and Cardiovascular Disease Later in Life, Study Finds

News

Hypertensive disorders of pregnancy (HDP) are more common in pregnant women with systemic lupus erythematosus than those without the chronic autoimmune disease, and pose an increased risk of heart disease ... Read more

February 5, 2020February 5, 2020

LFA and Lupus Canada Announce Catalyst Award to Fund Lupus Research

News

The Lupus Foundation of America (LFA) is partnering with Lupus Canada to fund the Lupus Canada Catalyst Award that supports research projects with potential to advance the field and improve ... Read more

February 3, 2020February 3, 2020

SLE Genetic Signature Seen That May Help in Personalized Treatment, Study Reports

News

A newly identified genetic signature may provide clues into the mechanisms underlying systemic lupus erythematosus (SLE), and open new potential avenues to personalized treatments. The research, “Integrated, multi-cohort analysis reveals ... Read more

January 20, 2020January 20, 2020

Two New Tools Can Reliably Measure Changes in Disease Activity in SLE, Study Finds

News

Two comprehensive tools can reliably measure changes in disease activity in people with systemic lupus erythematosus (SLE), a new study suggests. The findings support the use of these instruments — the ... Read more

January 10, 2020January 10, 2020

Dust Exposure, PTSD Linked to 9/11 Attacks May Raise Risk of Lupus, Other Autoimmune Diseases, Study Finds

News

Exposure to dust and having post-traumatic stress disorder (PTSD) as a result of the 9/11 terrorist attacks in New York are associated with an increased risk of developing autoimmune diseases ... Read more

December 20, 2019December 20, 2019

Childhood Abuse May Increase Risk of Developing SLE in Adulthood, Study Finds

News

Physical and emotional abuse during childhood may increase the risk of developing systemic lupus erythematosus (SLE) later in life, a new study has found. The study, “Association of Childhood Abuse ... Read more

December 13, 2019December 13, 2019

Study Supports Patient-reported Tool Measuring Fatigue’s Impact on Daily Activities

News

Fatigue has a major impact on quality of life in people with systemic lupus erythematosus, and measuring it using a patient-reported tool may prove useful in clinical trials, new research ... Read more

November 22, 2019November 22, 2019

Less SLE Disease Activity and Corticosteriod Use with Anifrolumab, Phase 3 TULIP 1 Trial Shows

News

Adding investigational anifrolumab to standard therapy lowers disease activity, limits the need for corticosteroids, and eases skin symptoms in people with moderate to severe systemic lupus erythematosus (SLE), a Phase ... Read more